Preparation and deployment of indigenous 125I-seeds for the treatment of prostate cancer: Dawn of prostate brachytherapy in India

被引:3
作者
Saxena, Sanjay Kumar [1 ]
Mukherjee, Archana [1 ]
Kumar, Yogendra [1 ]
Ram, Ramu [1 ]
Tapase, A. S. [1 ]
Anand, Vivek J. [2 ]
Dash, Ashutosh [1 ]
机构
[1] Bhabha Atom Res Ctr, Isotope Prod & Applicat Div, Mumbai 400085, Maharashtra, India
[2] PD Hinduja Natl Hosp & Med Res Ctr, Mumbai 400016, Maharashtra, India
基金
英国医学研究理事会;
关键词
I-125-seed; Bioevaluatin; Brachytherapy; Encapsulation; Prostate cancer; Quality control; Ultrasonography; I-125-BRACHYTHERAPY SEED; I-125; EYE;
D O I
10.1007/s10967-014-3521-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
'Permanent seed implantation' using I-125- seeds has emerged as an effective treatment modality for management of prostate cancer. An indigenous technology for the production of I-125 brachytherapy sources ('BARC I-125 Ocu-Prosta seed') has been developed. In this current work, we describe an overview of our experience on large scale production of I-125 brachytherapy sources, their quality assessment, in vivo bio-evaluation and initial experience on their journey from bench to bed-side for the treatment of prostate cancer.
引用
收藏
页码:1237 / 1243
页数:7
相关论文
共 21 条
[1]  
[Anonymous], 2001, SS3 AERB
[2]   Permanent implant prostate cancer brachytherapy: 2013 state-of-the art [J].
Cosset, J-M ;
Hannoun-Levi, J-M ;
Peiffert, D. ;
Delannes, M. ;
Pommier, P. ;
Pierrat, N. ;
Nickers, P. ;
Thomas, L. ;
Chauveinc, L. .
CANCER RADIOTHERAPIE, 2013, 17 (02) :111-117
[3]  
Ebara S, 2008, ACTA MED OKAYAMA, V62, P9
[4]  
International Organization for Standardization, 1992, 9978 ISO
[5]   Production of 125I from Neutron Irradiation of Natural Xe Gas and a Wet Distillation Process for Radiopharmaceutical Applications [J].
Joshi, P. V. ;
Jagadeesan, K. C. ;
Manolkar, R. B. ;
Mathakar, A. R. ;
Chirayil, Viju ;
Thakare, S. V. ;
Dash, Ashutosh ;
Pillai, M. R. A. .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2012, 51 (25) :8575-8582
[6]   125I monotherapy using D90 implant doses of 180 GY or greater [J].
Kao, Johnny ;
Stone, Nelson N. ;
Lavaf, Amir ;
Dumane, Vishruta ;
Cesaretti, Jamie A. ;
Stock, Richard G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (01) :96-101
[7]   Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer [J].
Langley, SEM ;
Laing, RW .
PROSTATE CANCER AND PROSTATIC DISEASES, 2004, 7 (03) :201-207
[8]   A novel approach for the adsorption of iodine-125 on silver wire as matrix for brachytherapy source for the treatment of eye and prostate cancer [J].
Mathew, C ;
Majali, MA ;
Balakrishnan, SA .
APPLIED RADIATION AND ISOTOPES, 2002, 57 (03) :359-367
[9]  
Maurer U, 2002, FRONT RADIAT THER ON, V36, P159
[10]   Permanent Interstitial Low-Dose-Rate Brachytherapy for Patients with Localised Prostate Cancer: A Systematic Review of Randomised and Nonrandomised Controlled Clinical Trials [J].
Peinemann, Frank ;
Grouven, Ulrich ;
Bartel, Carmen ;
Sauerland, Stefan ;
Borchers, Holger ;
Pinkawa, Michael ;
Heidenreich, Axel ;
Lange, Stefan .
EUROPEAN UROLOGY, 2011, 60 (05) :881-893